MENU

Overview

USC Stem Cell scientists are advancing our understanding of how the body develops, maintains and regenerates the heart, lungs and blood. They are also developing new regenerative treatments for the millions of patients with diseases of the heart, lungs, immune system and blood.

Statistics

  • Heart disease is the leading cause of death worldwide. In the US every year, about 610,000 people die of heart disease—the cause of one in four deaths.
  • An estimated 1.29 million people in the US are living with or in remission from blood cancer—leukemia, lymphoma or myeloma.
  • Globally, 36.7 million people are living with the autoimmune disease HIV, and 1.8 million of these are children. An estimated 35 million people have died from HIV-related causes so far.
  • More than 30,000 people in the US and 70,000 worldwide are living with the inherited lung disease cystic fibrosis, which limits the ability to breathe.

Researchers

News

Leukemia cells

How alike are the cancer cells from a single patient?

Even within a single patient with cancer, there is a vast diversity of individual tumor cells, which display distinct behaviors related to growth, metastasis, and responses to chemotherapy. To carry out these behaviors, each cancer cell uses its genes to make the needed molecules in a unique way known as its “gene expression signature.” To …

Students

California’s stem cell agency awards USC $5 million to train scientists and clinicians

USC has been awarded a $5 million training grant from the California Institute for Regenerative Medicine (CIRM) to prepare PhD students, postdoctoral researchers, and clinical fellows for careers in stem cell research. CIRM also approved 17 other training programs at universities and clinical facilities across California, including one at USC-affiliated Children’s Hospital Los Angeles (CHLA). …

Bell in the lab

Drug-like molecule points to novel strategies for cancer therapy

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes. In a new study in Cell Chemical Biology, a team of scientists led by Oliver Bell from USC and Stephen V. Frye from …

All Heart, Lung and Blood News

Multimedia

The University of Southern California has designed a unique “incubator” for scientists, engineers and clinicians to collaborate across disciplines and leverage the transformative power of stem cells to develop the future of regenerative medicine. The USC Stem Cell incubator trains the next generation of scientists through a dedicated PhD program and first-of-its-kind master’s degree, and brings together leading researchers from around the world to gain insights into developmental biology and advance new treatments for human disease. Learn more at http://stemcell.keck.usc.edu.
All Heart, Lung and Blood Videos

Stay connected.